Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

NCT00711035 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Baylor College of Medicine

Collaborators